NCT00314639View on ClinicalTrials.gov

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2008

Conditions
Schizophrenia and Schizophrenia Spectrum Psychosis
Interventions
DRUG

modafinil

Modafinil OR Placebo 100mg orally (on the morning) from day 0 to day 14 and 200mg orally (on the morning) from day 15 to day 28. AND REVERSE : Modafinil OR Placebo 100mg orally (on the morning) from day 42 to day 56 and 200mg orally (on the morning) from day 57 to day 70.

Trial Locations (1)

G1J 2G3

Centre Hospitalier Robert-Giffard, Québec

All Listed Sponsors
lead

Laval University

OTHER

NCT00314639 - Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter